EVALUACION DEL RENDIMIENTO CLINICO DE LOS PERFILES DE SINTOMAS ALERGICOS DE INMUNOCAP RAPID
Datos básicos
- Código:
- CTN3SP035
- Protocolo:
- CTN3SP035
- EUDRACT:
- NO ENCUENTRO
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
PHADIA AB
Resultados del Ensayo Clínico
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?
Nieto, Antonio; (...); Luis Subiza, Jose
Article. 10.1097/ACI.0000000000000854. 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.
Nieto, Antonio; (...); Casanovas, Miguel
Article. 10.1111/all.15374. 2022
Growth, Safety and Tolerance in Infants Fed Rice Protein Hydrolysate Formula: The GRITO Randomised Controlled Trial.
Lemoine, Anais; (...); Navas-Lopez, Victor Manuel
Article. 10.3390/nu17010162. 2024
Validation of the food allergy independent measure and the EuroPrevall food allergy quality of life questionnaire for children 8-12 years translated into Spanish.
Jang, Dah-Tay; (...); Mazon, Angel
Article. 10.15586/aei.v50i1.467. 2022